Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

Related Citations for PubMed (Select 22474603)

1.

Linking epigenetics to human disease and Rett syndrome: the emerging novel and challenging concepts in MeCP2 research.

Zachariah RM, Rastegar M.

Neural Plast. 2012;2012:415825. doi: 10.1155/2012/415825. Epub 2012 Feb 9. Review.

2.

MeCP2 dysfunction in Rett syndrome and related disorders.

Moretti P, Zoghbi HY.

Curr Opin Genet Dev. 2006 Jun;16(3):276-81. Epub 2006 May 2. Review.

PMID:
16647848
3.

The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis.

Forlani G, Giarda E, Ala U, Di Cunto F, Salani M, Tupler R, Kilstrup-Nielsen C, Landsberger N.

Hum Mol Genet. 2010 Aug 15;19(16):3114-23. doi: 10.1093/hmg/ddq214. Epub 2010 May 26.

4.

MeCP2 in Rett syndrome: transcriptional repressor or chromatin architectural protein?

Chadwick LH, Wade PA.

Curr Opin Genet Dev. 2007 Apr;17(2):121-5. Epub 2007 Feb 20. Review.

PMID:
17317146
5.

MECP2 mutations in Serbian Rett syndrome patients.

Djarmati A, Dobricić V, Kecmanović M, Marsh P, Jancić-Stefanović J, Klein C, Djurić M, Romac S.

Acta Neurol Scand. 2007 Dec;116(6):413-9.

PMID:
17986102
6.

The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: implication for pathogenesis of Rett syndrome.

Miyake K, Hirasawa T, Soutome M, Itoh M, Goto Y, Endoh K, Takahashi K, Kudo S, Nakagawa T, Yokoi S, Taira T, Inazawa J, Kubota T.

BMC Neurosci. 2011 Aug 8;12:81. doi: 10.1186/1471-2202-12-81.

7.

Evolving role of MeCP2 in Rett syndrome and autism.

LaSalle JM, Yasui DH.

Epigenomics. 2009 Oct;1(1):119-30. doi: 10.2217/epi.09.13. Review.

8.

Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.

Jentarra GM, Olfers SL, Rice SG, Srivastava N, Homanics GE, Blue M, Naidu S, Narayanan V.

BMC Neurosci. 2010 Feb 17;11:19. doi: 10.1186/1471-2202-11-19.

9.

Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype.

Hoffbuhr KC, Moses LM, Jerdonek MA, Naidu S, Hoffman EP.

Ment Retard Dev Disabil Res Rev. 2002;8(2):99-105. Review.

PMID:
12112735
10.

A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome.

Buschdorf JP, Strätling WH.

J Mol Med (Berl). 2004 Feb;82(2):135-43. Epub 2003 Nov 15.

PMID:
14618241
11.

MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.

Gadalla KK, Bailey ME, Cobb SR.

Biochem J. 2011 Oct 1;439(1):1-14. doi: 10.1042/BJ20110648. Review.

PMID:
21916843
12.

Mecp2-null mice provide new neuronal targets for Rett syndrome.

Urdinguio RG, Lopez-Serra L, Lopez-Nieva P, Alaminos M, Diaz-Uriarte R, Fernandez AF, Esteller M.

PLoS One. 2008;3(11):e3669. doi: 10.1371/journal.pone.0003669. Epub 2008 Nov 7.

13.

Regulation mechanism and research progress of MeCP2 in Rett syndrome.

Yang W, Pan H.

Yi Chuan. 2014 Jul;36(7):625-30. doi: 10.3724/SP.J.1005.2014.0625. Review.

PMID:
25076025
14.

MeCP2 Rett mutations affect large scale chromatin organization.

Agarwal N, Becker A, Jost KL, Haase S, Thakur BK, Brero A, Hardt T, Kudo S, Leonhardt H, Cardoso MC.

Hum Mol Genet. 2011 Nov 1;20(21):4187-95. doi: 10.1093/hmg/ddr346. Epub 2011 Aug 10.

15.

The methyl-CpG-binding protein MeCP2 and neurological disease.

Bird A.

Biochem Soc Trans. 2008 Aug;36(Pt 4):575-83. doi: 10.1042/BST0360575.

PMID:
18631120
16.

Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated protein MECP2 in vivo.

Kumar A, Kamboj S, Malone BM, Kudo S, Twiss JL, Czymmek KJ, LaSalle JM, Schanen NC.

J Cell Sci. 2008 Apr 1;121(Pt 7):1128-37. doi: 10.1242/jcs.016865. Epub 2008 Mar 11.

17.

[Research progress of Rett syndrome causing gene MECP2--the structure, function and modulation of MECP2].

Zhang JJ, Bao XH.

Beijing Da Xue Xue Bao. 2009 Dec 18;41(6):712-5. Review. Chinese.

18.
19.

Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients.

Lilja T, Wallenborg K, Björkman K, Albåge M, Eriksson M, Lagercrantz H, Rohdin M, Hermanson O.

Epigenetics. 2013 Mar;8(3):246-51. doi: 10.4161/epi.23752. Epub 2013 Jan 24.

20.

Rett syndrome: a surprising result of mutation in MECP2.

Dragich J, Houwink-Manville I, Schanen C.

Hum Mol Genet. 2000 Oct;9(16):2365-75. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk